Childhood Interstitial Lung Disease.

Childhood interstitial lung disease (chILD) is a heterogeneous group of diseases with various clinical and imaging findings. The incidence and prevalence have increased in recent years, probably due to better comprehension of these rare diseases and increased awareness among physicians. chILDs present with nonspecific pulmonary symptoms, such as tachypnea, hypoxemia, cough, rales, and failure to thrive. Unnecessary invasive procedures can be avoided if specific mutations are detected through genetic examinations or if typical imaging patterns are recognized on computed tomography. Disease knowledge and targeted therapies are improving through international collaboration. Pulmonary involvement in systemic diseases is not uncommon. Pulmonary involvement may be the first finding in connective tissue diseases. This review aims to present a systematic patient-targeted approach to the diagnosis of chILD.

[1]  B. Saha,et al.  Association between idiopathic pulmonary hemosiderosis and celiac disease in pediatric patients: A scoping review of the literature over the past 50 years , 2022, Pediatric pulmonology.

[2]  J. Dopazo,et al.  Incidence and Prevalence of Children's Diffuse Lung Disease in Spain. , 2021, Archivos de bronconeumologia.

[3]  C. Delacourt,et al.  Exposure to inorganic particles in paediatric sarcoidosis: the PEDIASARC study , 2021, Thorax.

[4]  M. Griese,et al.  Pulmonary alveolar proteinosis due to heterozygous mutation in OAS1: Whole lung lavages for long‐term bridging to hematopoietic stem cell transplantation , 2021, Pediatric pulmonology.

[5]  I. Tezcan,et al.  Respiratory system findings in pediatric patients with primary immunodeficiency , 2021, Pediatric pulmonology.

[6]  S. Ozen,et al.  Clinical spectrum of children with interstitial pneumonia with autoimmune features. , 2021, Respiratory medicine.

[7]  H. Omran,et al.  Multisystem Inflammation and Susceptibility to Viral infections in Human ZNFX1 Deficiency. , 2021, The Journal of allergy and clinical immunology.

[8]  F. Chiarelli,et al.  Type I Interferonopathies in Children: An Overview , 2021, Frontiers in Pediatrics.

[9]  C. Stock,et al.  Telomeres in Interstitial Lung Disease , 2021, Journal of clinical medicine.

[10]  T. Jin,et al.  Case Report: Novel SAVI-Causing Variants in STING1 Expand the Clinical Disease Spectrum and Suggest a Refined Model of STING Activation , 2021, Frontiers in Immunology.

[11]  M. García-nuñez,et al.  Detection of autoantibodies in bronchoalveolar lavage in patients with diffuse interstitial lung disease , 2021 .

[12]  Edward Y Lee,et al.  Pulmonary manifestations of immune dysregulation in CTLA‐4 haploinsufficiency and LRBA deficiency , 2021, Pediatric pulmonology.

[13]  Sheetu Singh,et al.  Interstitial Lung Diseases and Air Pollution: Narrative Review of Literature , 2021, Pulmonary Therapy.

[14]  N. Turcios,et al.  Pulmonary Manifestations of Genetic Disorders in Children. , 2021, Pediatric clinics of North America.

[15]  S. Pacheco,et al.  Pulmonary Manifestations of Immunodeficiency and Immunosuppressive Diseases Other than Human Immunodeficiency Virus. , 2021, Pediatric clinics of North America.

[16]  M. Sattler,et al.  FARS1‐related disorders caused by bi‐allelic mutations in cytosolic phenylalanyl‐tRNA synthetase genes: Look beyond the lungs! , 2021, Clinical genetics.

[17]  E. Yalcin,et al.  Complicated pneumonia due to exogenous toxic substances in children. , 2021, The Turkish journal of pediatrics.

[18]  V. Poletti,et al.  Lung involvement in monogenic interferonopathies , 2020, European Respiratory Review.

[19]  A. Kara,et al.  Nonmyeloablative hematopoietic stem cell transplantation in a patient with hereditary pulmonary alveolar proteinosis , 2020, Pediatric pulmonology.

[20]  E. Silverman,et al.  Epigenetics and pulmonary diseases in the horizon of precision medicine: a review , 2020, European Respiratory Journal.

[21]  T. Molina,et al.  Overview of STING-associated vasculopathy with onset in infancy (SAVI) among 21 patients. , 2020, The journal of allergy and clinical immunology. In practice.

[22]  B. Saha.  Idiopathic pulmonary hemosiderosis: A state of the art review. , 2020, Respiratory medicine.

[23]  M. Frémond,et al.  COPA syndrome, 5 years after: where are we? , 2020, Joint bone spine.

[24]  J. Karakaya,et al.  Risk factors for recurrent pulmonary exacerbation in idiopathic pulmonary hemosiderosis , 2020, Pediatric pulmonology.

[25]  N. Kiper,et al.  Variation in the bombesin staining of pulmonary neuroendocrine cells in pediatric pulmonary disorders—A useful marker for airway maturity , 2020, Pediatric pulmonology.

[26]  A. Bush,et al.  Pulmonary alveolar proteinosis in children , 2020, Breathe.

[27]  Edward Y Lee,et al.  Interstitial Lung Diseases in Children, Adolescents, and Young Adults: Different from Infants and Older Adults. , 2020, Radiologic clinics of North America.

[28]  C. Vancheri,et al.  Cryptogenic Organizing Pneumonia: Evolution of Morphological Patterns Assessed by HRCT , 2020, Diagnostics.

[29]  N. Kiper,et al.  Prospective evaluation of hydroxychloroquine in pediatric interstitial lung diseases: Study protocol for an investigator-initiated, randomized controlled, parallel-group clinical trial , 2020, Trials.

[30]  Jinrong Liu,et al.  Etiologic spectrum of interstitial lung diseases in Chinese children older than 2 years of age , 2020, Orphanet Journal of Rare Diseases.

[31]  N. Kiper,et al.  Childhood diffuse parenchymal lung diseases: We need a new classification , 2019, The clinical respiratory journal.

[32]  I. Tezcan,et al.  A clinical score to guide in decision making for monogenic type I IFNopathies , 2019, Pediatric Research.

[33]  A. Clément,et al.  Pulmonary Fibrosis in Children , 2019, Journal of clinical medicine.

[34]  A. Broomfield,et al.  Respiratory complications of metabolic disease in the paediatric population: A review of presentation, diagnosis and therapeutic options. , 2019, Paediatric respiratory reviews.

[35]  T. Soyer,et al.  Bilateral Pulmonary Langerhans's Cell Histiocytosis is Surgical Challenge in Children: A Case Report , 2019, European Journal of Pediatric Surgery Reports.

[36]  F. Pieruzzi,et al.  Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases , 2019, International journal of molecular sciences.

[37]  Yue Song,et al.  Clinical characteristics and prognosis of idiopathic pulmonary hemosiderosis in pediatric patients , 2018, The Journal of international medical research.

[38]  N. Kiper,et al.  Pulmonary complications following hematopoietic stem cell transplantation in children. , 2019, The Turkish journal of pediatrics.

[39]  P. Faverio,et al.  Long-term macrolides in diffuse interstitial lung diseases , 2017, European Respiratory Review.

[40]  T. Doyle,et al.  Lung Manifestations in the Rheumatic Diseases. , 2017, Chest.

[41]  M. Glassberg,et al.  Rheumatoid Arthritis-Associated Interstitial Lung Disease: Current Concepts , 2017, Current Rheumatology Reports.

[42]  A. Nicholson,et al.  International management platform for children’s interstitial lung disease (chILD-EU) , 2017, Thorax.

[43]  M. Ashworth,et al.  Interstitial Lung Disease in Children Made Easier…Well, Almost. , 2017, Radiographics : a review publication of the Radiological Society of North America, Inc.

[44]  M. Ashworth,et al.  Filamin A (FLNA) mutation—A newcomer to the childhood interstitial lung disease (ChILD) classification , 2017, Pediatric pulmonology.

[45]  D. Vizcaya,et al.  Pulmonary hypertension in childhood interstitial lung disease: A systematic review of the literature , 2017, Pediatric pulmonology.

[46]  I. Tezcan,et al.  Diagnosis of Interstitial Lung Disease Caused by Possible Hypersensitivity Pneumonitis in a Child: Think CGD , 2017, Journal of Clinical Immunology.

[47]  R. Epaud,et al.  Management of children with interstitial lung diseases: the difficult issue of acute exacerbations , 2016, European Respiratory Journal.

[48]  Edward Y Lee,et al.  Current Update on Interstitial Lung Disease of Infancy: New Classification System, Diagnostic Evaluation, Imaging Algorithms, Imaging Findings, and Prognosis. , 2016, Radiologic clinics of North America.

[49]  U. Ozcelik,et al.  Diagnosis and treatment of pulmonary alveolar microlithiasis , 2016, Pediatrics international : official journal of the Japan Pediatric Society.

[50]  Atul Gupta,et al.  Genetic disorders of surfactant protein dysfunction: when to consider and how to investigate , 2016, Archives of Disease in Childhood.

[51]  T. Vece,et al.  Update on Diffuse Lung Disease in Children. , 2016, Chest.

[52]  A. Baruchel,et al.  Eosinophilic pneumonias in children: A review of the epidemiology, diagnosis, and treatment , 2016, Pediatric pulmonology.

[53]  A. Bush,et al.  ERS statement on the multidisciplinary respiratory management of ataxia telangiectasia , 2015, European Respiratory Review.

[54]  P. Zanen,et al.  Telomere length in interstitial lung diseases. , 2015, Chest.

[55]  D. Lynch,et al.  An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features , 2015, European Respiratory Journal.

[56]  A. Nicholson,et al.  European protocols for the diagnosis and initial treatment of interstitial lung disease in children , 2015, Thorax.

[57]  C. Delacourt,et al.  Biallelic Mutations of Methionyl-tRNA Synthetase Cause a Specific Type of Pulmonary Alveolar Proteinosis Prevalent on Réunion Island. , 2015, American journal of human genetics.

[58]  B. Carter,et al.  Idiopathic pulmonary haemosiderosis: spectrum of thoracic imaging findings in the adult patient. , 2015, Clinical radiology.

[59]  M. Griese,et al.  Hydroxychloroquine in children with interstitial (diffuse parenchymal) lung diseases , 2015, Pediatric pulmonology.

[60]  S. Lau,et al.  Genotype alone does not predict the clinical course of SFTPC deficiency in paediatric patients , 2015, European Respiratory Journal.

[61]  S. Bano,et al.  Pulmonary Langerhans cell histiocytosis in children: a spectrum of radiologic findings. , 2014, European journal of radiology.

[62]  M. Mäkelä,et al.  Neuroendocrine cell hyperplasia of infancy: a prospective follow-up of nine children , 2012, Archives of Disease in Childhood.

[63]  U. Ozcelik,et al.  Different features of lung involvement in Niemann-Pick disease and Gaucher disease. , 2012, Respiratory medicine.

[64]  U. Ozcelik,et al.  Pulmonary alveolar microlithiasis: a case report and review of the literature , 2012, European Journal of Pediatrics.

[65]  M. Dishop.  Paediatric interstitial lung disease: classification and definitions. , 2011, Paediatric respiratory reviews.

[66]  T. Vece,et al.  Interstitial Lung Disease in Children Older Than 2 Years. , 2010, Pediatric allergy, immunology, and pulmonology.

[67]  R. Deterding.  Infants and Young Children with Children's Interstitial Lung Disease. , 2010, Pediatric allergy, immunology, and pulmonology.

[68]  R. Epaud,et al.  Interstitial lung diseases in children , 2010, Orphanet journal of rare diseases.

[69]  M. Griese,et al.  Incidence and classification of pediatric diffuse parenchymal lung diseases in Germany , 2009, Orphanet journal of rare diseases.

[70]  U. Ozcelik,et al.  Successful unilateral partial lung lavage in a child with pulmonary alveolar proteinosis. , 2009, Journal of clinical anesthesia.

[71]  A. Clément,et al.  Interstitial lung diseases in infants and children , 2008, European Respiratory Journal.

[72]  U. Ozcelik,et al.  Hypersensitivity pneumonitis in children: pigeon breeders disease , 2004, Annals of tropical paediatrics.

[73]  N. Kiper,et al.  Postinfectious Bronchiolitis obliterans in Children: Clinical and Radiological Profile and Prognostic Factors , 2003, Respiration.

[74]  N. Sharief,et al.  Idiopathic interstitial pneumonitis in children: A national survey in the United Kingdom and Ireland , 2002, Pediatric pulmonology.

[75]  L. Fan.  Hypersensitivity pneumonitis in children , 2002, Current opinion in pediatrics.

[76]  D. Manson,et al.  Pulmonary interstitial glycogenosis: a new variant of neonatal interstitial lung disease. , 2002, American journal of respiratory and critical care medicine.

[77]  Paul J. Friedman,et al.  American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors , 2002, American journal of respiratory and critical care medicine.

[78]  M. Gülsün,et al.  Treatment and follow-up of pulmonary alveolar microlithiasis with disodium editronate: radiological demonstration , 2002, Pediatric Radiology.

[79]  R. Castile,et al.  Technique and clinical applications of full-inflation and end-exhalation controlled-ventilation chest CT in infants and young children , 2001, Pediatric Radiology.

[80]  K. Collins,et al.  A telomerase component is defective in the human disease dyskeratosis congenita , 1999, Nature.

[81]  M. Villa,et al.  Bronchoalveolar lavage cell analysis in a child with chronic lipid pneumonia. , 1998, The European respiratory journal.

[82]  N. Kiper,et al.  Treatment of pulmonary alveolar microlithiasis with a diphosphonate--preliminary results of a case. , 1992, Respiration; international review of thoracic diseases.